Englander Institute for Precision Medicine
Found 797 results
Author Title Type [ Year(Asc)]
Filters: Clinical-trials-corner-issue-10(1) is   [Clear All Filters]
2023
Rowdo FPMadorsky, Xiao G, Khramtsova GF, Nguyen J, Olopade OI, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK et al..  2023.  Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.. bioRxiv.
Askari E, Moghadam SZarehparva, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CMaria, Walter MAlexander et al..  2023.  Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.. J Nucl Med Technol. 51(1):22-25.
Borregales LD, Venkat S, Calderon LPosada, Lewicki P, Flynn T, Faltas BM, Molina AM, Golombos DM, O'Malley P, Scherr DS.  2023.  A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer.. Eur Urol. 84(6):604-606.
Hussain M, Sternberg CN, Efstathiou E, Fizazi K, Shen Q, Lin X, Sugg J, Steinberg J, Noerby B, De Giorgi U et al..  2023.  Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide? Future Oncol. 19(29):1953-1960.
Benedetti E, Chetnik K, Flynn T, Barbieri CE, Scherr DS, Loda M, Krumsiek J.  2023.  Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort.. Sci Data. 10(1):830.
Kandola MS, Kulm S, Kim LK, Markowitz SM, Liu CF, Thomas G, Ip JE, Lerman BB, Elemento O, Cheung JW.  2023.  Population-Level Prevalence of Rare Variants Associated With Atrial Fibrillation and its Impact on Patient Outcomes.. JACC Clin Electrophysiol.
Charilaou P, Mohapatra S, Doukas S, Kohli M, Radadiya D, Devani K, Broder A, Elemento O, Lukin DJ, Battat R.  2023.  Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.. J Gastroenterol Hepatol. 38(2):241-250.
Stangl-Kremser J, Sun M, Ho B, Thomas J, Nauseef JT, Osborne JR, Molina A, Sternberg CN, Nanus DM, Bander NH et al..  2023.  Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.. Prostate. 83(14):1351-1357.
Parent P, Auclin E, Patrikidou A, Mezquita L, Chanzá NMartínez, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R et al..  2023.  Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.. Cancers (Basel). 15(4)
Guilbaud E, Spada S, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Aretz A, Buqué A, Yamazaki T, Demaria S et al..  2023.  Quantitative assessment of mitophagy in irradiated cancer cells.. Methods Cell Biol. 174:93-111.
Sato A, Kraynak J, Marciscano AE, Galluzzi L.  2023.  Radiation therapy: An old dog learning new tricks.. Methods Cell Biol. 180:xv-xxv.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche J-B, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L et al..  2023.  Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.. Cell Death Dis. 14(5):305.
Pouget J-P, Chan TA, Galluzzi L, Constanzo J.  2023.  Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors.. Trends Cancer. 9(11):968-981.
Marciscano AE, Wolfe S, Zhou XKathy, Barbieri CE, Formenti SC, Hu JC, Molina AM, Nanus DM, Nauseef JT, Scherr DS et al..  2023.  Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).. BMC Cancer. 23(1):781.
Jbara A, Lin K-T, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, Elyada E, Mogilevsky M, Raitses-Gurevich M, Johnson JL et al..  2023.  RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.. Nature. 617(7959):147-153.
Xu D, Forbes ANeil, Cohen S, Palladino A, Karadimitriou T, Khurana E.  2023.  Recapitulation of patient-specific 3D chromatin conformation using machine learning.. Cell Rep Methods. 3(9):100578.
Falvo DJ, Grimont A, Zumbo P, Fall WB, Yang JL, Osterhoudt A, Pan G, Rendeiro AF, Meng Y, Wilkinson JE et al..  2023.  A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas.. Dev Cell. 58(24):2959-2973.e7.
Matsubara N, de Bono J, Sweeney C, Chi KN, Olmos D, Sandhu S, Massard C, Garcia J, Chen G, Harris A et al..  2023.  Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer.. Clin Genitourin Cancer. 21(2):230-237.e1.
Higgins CA, Nilsson-Payant BE, Bonaventure B, Kurland AP, Ye C, Yaron TM, Johnson JL, Adhikary P, Golynker I, Panis M et al..  2023.  SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.. mBio. :e0100723.
Chin AF, Han J, Clement CC, Choi Y, Zhang H, Browne M, Jeon OHee, Elisseeff JH.  2023.  Senolytic treatment reduces oxidative protein stress in an aging male murine model of post-traumatic osteoarthritis.. Aging Cell. 22(11):e13979.
You J, Reilly MD, Eljalby M, Bareja R, Yusupova M, Vyas NS, Bang J, Ding W, Desman G, Miller LS et al..  2023.  Soluble adenylyl cyclase contributes to imiquimod-mediated inflammation and is a potential therapeutic target in psoriasis.. Exp Dermatol. 32(7):1051-1062.
Geng C, Zhang M-C, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, Wu C, Park S, Kondraganti S, Wang D et al..  2023.  SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.. Clin Cancer Res. 29(21):4464-4478.
Luo Y, Yamada M, N'Tumba-Byn T, Asif H, Gao M, Hu Y, Marangoni P, Liu Y, Evans T, Rafii S et al..  2023.  SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline†.. Biol Reprod. 109(4):533-551.
Wilczyñski JManuel Ort, Mena HAgustina, Ledesma MManuel, Olexen CMariel, Podaza E, Schattner M, Negrotto S, Errasti AEmilse, Silva EAntonio Ca.  2023.  The synthetic phospholipid C8-C1P determines pro-angiogenic and pro-reparative features in human macrophages restraining the proinflammatory M1-like phenotype.. Front Immunol. 14:1162671.
Paiella S, Azzolina D, Gregori D, Malleo G, Golan T, Simeone DM, Davis MB, Vacca PG, Crovetto A, Bassi C et al..  2023.  A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing.. ESMO Open. 8(2):100881.